Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples

NCT00644163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1070

Last updated 2014-01-27

No results posted yet for this study

Summary

This study will evaluate the effectiveness of a risk-reduction program in preventing the transmission of HIV and sexually transmitted diseases among African-American heterosexual couples, with one partner having been previously diagnosed with an HIV infection.

Conditions

  • HIV Infections
  • Sexually Transmitted Disease

Interventions

BEHAVIORAL

Eban HIV/STD Risk Reduction Intervention

The eight-session Eban HIV/STD Risk Reduction Intervention is embedded in a cultural context and is gender tailored in its prevention messages and activities. Sessions will focus on the couple and will teach the couple about communication skills. The approach will draw upon social cognitive theory, an ecological framework, and HIV/STD risk-reduction research with inner-city African-American populations.

BEHAVIORAL

Eban Health Promotion Intervention

The eight-session Eban Health Promotion Intervention is guided by a social cognitive approach that engages health promotion skills. Sessions will focus on the individual and will provide factual information on health, screening, exercise, diet management, and medication adherence.

Sponsors & Collaborators

Principal Investigators

  • John Jemmott, PhD · University of Pennsylvania

  • Nabila el-Bassel, DSW · Columbia University

  • Gail Wyatt, PhD · University of California, Los Angeles

  • Gina Wingood, ScD · Emory University

  • J. Richard Landis, PhD · University of Pennsylvania/Data Coordinating Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-11-30
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00644163 on ClinicalTrials.gov